Reforming the European Chemicals Agency: Strengthening Safety, Transparency, and Cooperation

What the Changes Do

The European Parliament has updated the rules for the European Chemicals Agency (ECHA). These changes allow the Agency to improve its operations, increase its transparency, and work more closely with other EU bodies and the public.

The amendments cover many aspects of the Agency, including its mission, structure, funding, and how it cooperates with other EU agencies. Overall, the goal is to strengthen the EU’s chemicals policy to make it safer for people, animals, the environment, and the economy.

Expanded Mission and Focus

The Agency’s responsibilities are broader than before. It is now required to:

• Safety Scope: Protect human health, the environment, and vulnerable groups (such as children and pregnant women) from chemical hazards.
• Sustainability: Include environmental sustainability in its focus on chemicals, mixtures, and articles.
• Market Support: Support the safe circulation of chemicals across the EU market.
• Innovation: Promote non-animal testing methods and help research into safer alternatives.
• Business Support: Assist small and medium-sized enterprises (SMEs) with compliance costs and rules.
• Health Research: Support research and innovation, including studying all exposures that affect health (known as “exposomics”).

Organizational Improvements

The structure of the Agency is being updated to improve governance and input from various groups:

• Management Board: The Board must now include a balanced mix of experts and must follow stricter rules regarding conflicts of interest.
• Stakeholder Input: A new Assembly of accredited stakeholders has been created. This body brings together industry, NGOs, and scientists to provide input and hold the Agency accountable.
• Cross-Sectoral Work: A permanent Task Force will coordinate efforts across multiple EU agencies (including EFSA, EMA, and ECDC) to manage "One Health" issues (covering human, animal, plant, and environmental health) and exposome research.
• Committees: The existing committees will continue to operate, but their members must be chosen for their expertise, gender balance, and independence.

Transparency and Accountability

The amendments introduce stricter rules regarding public access and financial oversight:

• Public Records: The Agency must post all requests for scientific opinions, their status, and the final opinions on its website.
• Expert List: It must maintain a public list detailing its experts, their qualifications, and any conflicts of interest.
• Annual Reporting: The Agency must publish an annual report detailing:
• How it spent its money.
• How it handled requests and opinions.
• Any attempts to influence its work.
• The status of its reserve fund.
• Financial Stability: The Agency can create a reserve fund from surplus fees. This fund is designed to keep the Agency financially stable and smooth out large changes in revenue.

Independence and Cooperation

• Staff Independence: Staff and experts must remain free from conflicts of interest and cannot take instructions from any government or private body.
• Disagreement Protocol: If the Agency and another body disagree on a scientific issue, they must produce a joint, public report explaining the disagreement and the reasons for the different views.
• Inter-Agency Cooperation: The Agency will work closely with other EU bodies, such as the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA), through the permanent task force.

Summary of Key Changes

In short, the amendments make the European Chemicals Agency:

• Broader in scope: Covering environmental sustainability and vulnerable groups.
• More transparent: Making all requests, opinions, and financial data publicly available.
• Better organized: Establishing a stakeholder assembly and a permanent task force for cross-sectoral work.
• More independent: Implementing strict rules for staff and experts to prevent conflicts of interest.
• More collaborative: Establishing clear processes for working with and resolving disagreements with other EU agencies.

Broader context

The amendments to the European Chemicals Agency (ECHA) regulation are part of the EU’s broader Green Deal and Chemicals Strategy for Sustainability (CSS). This strategy aims to:

• Phase out harmful chemicals from consumer products and the environment.
• Promote safer alternatives to toxic substances, especially in products used daily (e.g., toys, cosmetics, packaging).
• Align with global sustainability goals, such as the UN Sustainable Development Goals (SDGs), particularly those related to health, clean water, and responsible consumption.
• Support the EU’s zero-pollution ambition, which seeks to reduce pollution in air, water, and soil to levels no longer harmful to human health or ecosystems.

The changes also reflect a growing focus on One Health, a concept recognizing that the health of humans, animals, and ecosystems are interconnected. The exposome approach—studying all environmental exposures (chemical, physical, biological) that affect health—is a key part of this.

The legislation builds on existing EU chemical regulations, such as REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals), but expands ECHA’s role to ensure greater coordination with other EU agencies (e.g., EFSA for food safety, EMA for medicines, EEA for environment) to address complex, cross-sectoral challenges like endocrine disruptors or microplastics.

Impact on people living in the EU

Health and safety

• Stronger protection for vulnerable groups: The amendments explicitly require ECHA to consider the needs of children, pregnant women, and other at-risk populations when assessing chemical risks. This could lead to stricter limits or bans on chemicals linked to developmental or reproductive harm.
• Reduced exposure to harmful substances: By prioritizing environmental sustainability and substitution of hazardous chemicals, the EU aims to lower the presence of toxic substances in everyday products, from cleaning supplies to electronics.
• Non-animal testing: The push for alternative testing methods (e.g., computer models, cell-based tests) may accelerate the development of safer chemicals without relying on animal testing, aligning with ethical and scientific advancements.

Transparency and trust

• Public access to information: Citizens can now see all requests for scientific opinions, their status, and final decisions on ECHA’s website. This includes conflicts of interest of experts, ensuring greater accountability.
• Annual reports: ECHA must publish details on its funding, decision-making, and external influences, making it easier for the public to scrutinize its work.

Economic and market effects

• Support for SMEs: Small and medium-sized businesses will receive more guidance and financial help to comply with chemical regulations, reducing the burden of complex rules.
• Free circulation of chemicals: The amendments aim to maintain a single EU market for chemicals, ensuring that safe products can be traded across member states without unnecessary barriers.

Environmental benefits

• Sustainability focus: By integrating environmental sustainability into ECHA’s mission, the EU is prioritizing the long-term health of ecosystems, which indirectly benefits people through cleaner air, water, and soil.
• Coordination on exposome research: The new task force with other EU agencies will improve understanding of how multiple chemical exposures (e.g., from air pollution, food, and consumer products) combine to affect health, leading to more holistic policies.

Global influence

• Setting standards: The EU’s stricter chemical regulations often influence global standards, as companies may adopt the same safety measures for all markets. This can lead to safer products worldwide, even in countries outside the EU.